Concord Biotech gets FDA nod for immunosuppressant mycophenolate mofetil

Concord Biotech gains 6% on USFDA nod for drug with $30 million US market opportunity

Shares of Concord Biotech Ltd. are trading higher by 6% on Wednesday, June 3, after the company received approval from the US Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Mycophenolate Mofetil for Oral Suspension USP, 200 mg/mL. Mycophenolate mofetil is an immunosuppressant used to prevent organ rejection in adult…

Read More
Deven Choksey sees limited downside in IT stocks; prefers KPIT, Tata Technologies and Tata Elxsi

Deven Choksey sees limited downside in IT stocks; prefers KPIT, Tata Technologies and Tata Elxsi

Indian IT stocks could offer attractive opportunities after the recent correction, according to Deven Choksey, MD, DRChoksey FinServ. He believes downside risks are limited as companies adapt to AI-driven, outcome-based business models. Choksey prefers engineering and automotive technology companies such as KPIT Technologies, Tata Technologies and Tata Elxsi, citing strong order visibility and execution prospects….

Read More
Ridham Desai says AI boom may delay return of foreign flows to India

Ridham Desai says AI boom may delay return of foreign flows to India

Foreign investor interest in India remains low because global investors are finding stronger earnings growth opportunities in markets tied to the artificial intelligence (AI) supply chain, according to Ridham Desai, Chief Equity Strategist, India, at Morgan Stanley. Speaking at the Morgan Stanley Investor Forum 2026, Desai said the global AI-led capital expenditure cycle remains intact…

Read More
Explained - The key trigger behind Borosil Renewables share price surge on Wednesday

Explained – The key trigger behind Borosil Renewables share price surge on Wednesday

Shares of Borosil Renewables Ltd. gained as much as 8% on Wednesday, June 3, after the Government imposed a countervailing duty (CVD) on “Textured Toughened (Tempered) Glass” made or exported from Malaysia. The move was announced as part of the Notification No. 02/2026-Customs (CVD). Contours Of The Notification The duty is effective for a period…

Read More
Shilpa Medicare Q4 Results: Shares gain on sharp Q4 profit growth, exceptional gains boost earnings

Shilpa Medicare to acquire 30.4% stake in Spain’s Gate2Brain with €7 million investment

Shares of Shilpa Medicare Ltd. are in focus after the company announced a strategic investment in Spain-based biotechnology firm Gate2Brain, marking its latest bet on innovative therapies targeting central nervous system (CNS) disorders and rare cancers. In an exchange filing on Wednesday, Shilpa Medicare said its wholly owned subsidiary, Shilpa Biocare Pvt Ltd, will acquire…

Read More